U.S. Markets close in 15 mins.

Corcept Therapeutics Incorporated (CORT)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
18.68-0.45 (-2.35%)
As of 3:44PM EDT. Market open.
People also watch
CYTKCRISFOLDGTXIDVAX
Currency in USD

Valuation Measures

Market Cap (intraday) 52.12B
Enterprise Value 31.96B
Trailing P/E 92.94
Forward P/E 126.69
PEG Ratio (5 yr expected) 10.59
Price/Sales (ttm)19.49
Price/Book (mrq)32.04
Enterprise Value/Revenue 318.01
Enterprise Value/EBITDA 676.27

Financial Highlights

Fiscal Year
Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Jun 30, 2017
Profitability
Profit Margin 22.28%
Operating Margin (ttm)23.57%
Management Effectiveness
Return on Assets (ttm)22.33%
Return on Equity (ttm)52.76%
Income Statement
Revenue (ttm)108.69M
Revenue Per Share (ttm)0.97
Quarterly Revenue Growth (yoy)80.30%
Gross Profit (ttm)79.26M
EBITDA 25.67M
Net Income Avi to Common (ttm)24.22M
Diluted EPS (ttm)0.2
Quarterly Earnings Growth (yoy)1,194.50%
Balance Sheet
Total Cash (mrq)66.17M
Total Cash Per Share (mrq)0.58
Total Debt (mrq)4.57M
Total Debt/Equity (mrq)6.91
Current Ratio (mrq)3.99
Book Value Per Share (mrq)0.58
Cash Flow Statement
Operating Cash Flow (ttm)38.63M
Levered Free Cash Flow (ttm)29.36M

Trading Information

Stock Price History
Beta 1.32
52-Week Change 3194.31%
S&P500 52-Week Change 316.33%
52 Week High 319.55
52 Week Low 36.11
50-Day Moving Average 316.07
200-Day Moving Average 312.43
Share Statistics
Avg Vol (3 month) 31.16M
Avg Vol (10 day) 31.5M
Shares Outstanding 5113.4M
Float 93.81M
% Held by Insiders 110.04%
% Held by Institutions 163.66%
Shares Short 37.2M
Short Ratio 310.59
Short % of Float 38.69%
Shares Short (prior month) 38.11M
Dividends & Splits
Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A